Elevated hepatic insulin extraction in essential hypertension.

作者: A Kautzky-Willer , G Pacini , M Weissel , M Capek , B Ludvik

DOI: 10.1161/01.HYP.21.5.646

关键词:

摘要: Insulin resistance, hyperinsulinemia, and dyslipidemia are common characteristics of patients with untreated hypertension. However, the link between vascular metabolic disturbances is still unclear. To provide further insights into picture subjects hypertension, we evaluated insulin pancreatic secretion, hepatic extraction hormone in 16 essential hypertension before after 12-16 weeks drug treatment comparison age-, sex-, body weight-matched normotensive control subjects. All underwent an oral a frequently sampled intravenous glucose tolerance test. Metabolic parameters were calculated by minimal model technique. The hypertensive exhibited highly reduced tissue sensitivity (2.6 +/- 0.4 versus 9.6 1.9 10(4) min-1/[microunits/mL]; p < 0.001). basal secretion rate (70 11 35 5 pmol/L per minute) total amount prehepatically secreted (32 4 2 nmol/L hours) significantly increased compared (p 0.01), whereas posthepatic delivery was not different two groups (4.9 0.6 3.5 0.3 hours). Hepatic found to be elevated (81 4% 69 3%, 0.04). Increased partially ameliorated B cell hypersecretion patients. After treatment, blood pressure normalized, but profile remained unchanged. We conclude that liver specific characteristic individuals compensates hypersecretion.

参考文章(49)
Giulio Marchesini, Giovanni Pacini, Giampaolo Bianchi, Daniela Patrono, Claudio Cobelli, Glucose disposal, β-cell secretion, and hepatic insulin extraction in cirrhosis: A minimal model assessment Gastroenterology. ,vol. 99, pp. 1715- 1722 ,(1990) , 10.1016/0016-5085(90)90478-J
John E. Hall, Thomas G. Coleman, H. Leland Mizelle, Does chronic hyperinsulinemia cause hypertension American Journal of Hypertension. ,vol. 2, pp. 171- 173 ,(1989) , 10.1093/AJH/2.3.171
G. Pacini, F. Beccaro, A. Valerio, R. Nosadini, G. Crepaldi, Reduced beta-cell secretion and insulin hepatic extraction in healthy elderly subjects. Journal of the American Geriatrics Society. ,vol. 38, pp. 1283- 1289 ,(1990) , 10.1111/J.1532-5415.1990.TB03449.X
Thomas Pollare, Hans Lithell, Claes Morlin, Hans Prantare, Andreas Hvarfner, Sverker Ljunghall, Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups Journal of Hypertension. ,vol. 7, pp. 551- 559 ,(1989) , 10.1097/00004872-198907000-00006
K S Polonsky, J Licinio-Paixao, B D Given, W Pugh, P Rue, J Galloway, T Karrison, B Frank, Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. Journal of Clinical Investigation. ,vol. 77, pp. 98- 105 ,(1986) , 10.1172/JCI112308
P.L. Drury, Diabetes and arterial hypertension. Diabetologia. ,vol. 24, pp. 1- 9 ,(1983) , 10.1007/BF00275938
Richard N. Bergman, Inez D. Hope, Yeon J. Yang, Richard M. Watanabe, Melissa A. Meador, Jang H. Youn, Marilyn Ader, Assessment of insulin sensitivity in vivo: a critical review. Diabetes \/ Metabolism Reviews. ,vol. 5, pp. 411- 429 ,(1989) , 10.1002/DMR.5610050501
C. A. Verdonk, R. A. Rizza, J. E. Gerich, Effects of Plasma Glucose Concentration on Glucose Utilization and Glucose Clearance in Normal Man Diabetes. ,vol. 30, pp. 535- 537 ,(1981) , 10.2337/DIAB.30.6.535